Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hyperopia: early-phase trial registry
2 of 11 indexed Hyperopia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,578 of 28,963 conditions by registered trial count.
11 US clinical trials · 2 currently recruiting · #1,578 of 28,963 conditions by registered trial count
Hyperopia: 11 US clinical trials tracked, 2 recruiting.
Hyperopia is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is CooperVision International Limited (CVIL), running 2 of these trials.
Open enrollment, early-phase tilt
Hyperopia has 11 registered US clinical trials, 2 of them open to new participants right now, about 18% of the total.
- 2
- recruiting participants now
- 18%
- of trials open to enrollment
- 0
- in Phase 3-4 (later-stage)
- 2
- top sponsor: CooperVision International Limited (CVIL)
Corpus placement: #1,578 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Hyperopia on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Hyperopia is recruiting below its size-band peers.
2 of 11 indexed trials (18.2%) are open to enrollment, against a 46.5% average across 28,061 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hyperopia research.
CooperVision International Limited (CVIL) accounts for 2 of 11 trials (18.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Hyperopia enrolment sits around 80 participants.
Median target enrolment is 80 among the 11 trials that report a genuine target (sentinel values excluded). 6 of those (54.5%) plan for fewer than 100 participants.
-
Hyperopia research is mostly interventional.
10 interventional and 1 observational studies make up this index (90.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Comprehensive Assessment of Multiple Products (CAMP)
CooperVision International Limited (CVIL)
NCT07276347
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
CooperVision International Limited (CVIL)
NCT06869044
Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism
Bausch & Lomb Incorporated
NCT05264623
Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation
Jaeb Center for Health Research
NCT01515475
Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors
Abbott Medical Optics
NCT01675479
Air Optix Night and Day Aqua (AONDA) Retrospective Study 1
Alcon Research
NCT05790928
A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia
Bausch & Lomb Incorporated
NCT00348205
Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers
CooperVision
NCT06098339
Apioc Contact Lens Feasibility
Lentechs
NCT03688672
Clinical Investigation of the WaveLight® EX500 Excimer Laser
Alcon Research
NCT04805593
Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control
University of Florida
NCT05477875
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Hyperopia right now
2 recruiting of 11 indexed (18% open).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top sponsor: CooperVision International Limited (CVIL) (2 trials), 7 others listed. 11 shown below, recruiting first. #1,578 of 28,963 conditions by registered trial count.
Why a small condition index still matters
Thin indexes still surface the registry rows that exist for this label. Counts stay small when ClinicalTrials.gov lists few studies under the condition string, not because this page omits rows. Verify any enrollment decision on ClinicalTrials.gov and with a clinician.
Frequently Asked Questions
How many clinical trials are there for Hyperopia?
PlainTrial tracks 11 US clinical trials for Hyperopia, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Hyperopia?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.